References
1. Ananth CV, Duzyj CM, Yadava S, Schwebel M, Tita ATN, Joseph KS.
Changes in the Prevalence of Chronic Hypertension in Pregnancy, United
States, 1970 to 2010. Hypertension. 2019;74(5):1089-95.
2. Kim SY, Dietz PM, England L, Morrow B, Callaghan WM. Trends in
pre-pregnancy obesity in nine states, 1993-2003. Obesity (Silver
Spring). 2007;15(4):986-93.
3. Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in
Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and
Age, 2007-2008 to 2015-2016. JAMA. 2018;319(16):1723-5.
4. Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Kirmeyer S, Mathews
TJ, et al. Births: final data for 2009. Natl Vital Stat Rep.
2011;60(1):1-70.
5. Misra DP, Ananth CV. Infant mortality among singletons and twins in
the United States during 2 decades: effects of maternal age. Pediatrics.
2002;110(6):1163-8.
6. Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM,
Kuklina EV. Prevalence, trends, and outcomes of chronic hypertension: a
nationwide sample of delivery admissions. Am J Obstet Gynecol.
2012;206(2):134 e1-8.
7. Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM.
Pregnancy-related mortality in the United States, 2006-2010. Obstet
Gynecol. 2015;125(1):5-12.
8. Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell
LC. Chronic hypertension and pregnancy outcomes: systematic review and
meta-analysis. BMJ. 2014;348:g2301.
9. Sutton EF, Hauspurg A, Caritis SN, Powers RW, Catov JM. Maternal
Outcomes Associated With Lower Range Stage 1 Hypertension. Obstet
Gynecol. 2018;132(4):843-9.
10. Williams MA, Mittendorf R, Monson RR. Chronic hypertension,
cigarette smoking, and abruptio placentae. Epidemiology.
1991;2(6):450-3.
11. Ananth CV, Vintzileos AM. Ischemic placental disease: epidemiology
and risk factors. Eur J Obstet Gynecol Reprod Biol. 2011;159(1):77-82.
12. Wu P, Chew-Graham CA, Maas AH, Chappell LC, Potts JE, Gulati M, et
al. Temporal Changes in Hypertensive Disorders of Pregnancy and Impact
on Cardiovascular and Obstetric Outcomes. Am J Cardiol.
2020;125(10):1508-16.
13. Wu CC, Chen SH, Ho CH, Liang FW, Chu CC, Wang HY, et al. End-stage
renal disease after hypertensive disorders in pregnancy. Am J Obstet
Gynecol. 2014;210(2):147 e1-8.
14. Cirillo PM, Cohn BA. Pregnancy complications and cardiovascular
disease death: 50-year follow-up of the Child Health and Development
Studies pregnancy cohort. Circulation. 2015;132(13):1234-42.
15. Grandi SM, Filion KB, Yoon S, Ayele HT, Doyle CM, Hutcheon JA, et
al. Cardiovascular Disease-Related Morbidity and Mortality in Women With
a History of Pregnancy Complications. Circulation. 2019;139(8):1069-79.
16. Ankumah NA, Cantu J, Jauk V, Biggio J, Hauth J, Andrews W, et al.
Risk of adverse pregnancy outcomes in women with mild chronic
hypertension before 20 weeks of gestation. Obstet Gynecol.
2014;123(5):966-72.
17. Ananth CV, Savitz DA, Bowes WA, Jr. Hypertensive disorders of
pregnancy and stillbirth in North Carolina, 1988 to 1991. Acta Obstet
Gynecol Scand. 1995;74(10):788-93.
18. Panaitescu AM, Syngelaki A, Prodan N, Akolekar R, Nicolaides KH.
Chronic hypertension and adverse pregnancy outcome: a cohort study.
Ultrasound Obstet Gynecol. 2017;50(2):228-35.
19. Nzelu D, Dumitrascu-Biris D, Kay P, Nicolaides KH, Kametas NA.
Severe hypertension, preeclampsia and small for gestational age in women
with chronic hypertension diagnosed before and during pregnancy.
Pregnancy Hypertens. 2018;14:200-4.
20. Ananth CV, Basso O. Impact of pregnancy-induced hypertension on
stillbirth and neonatal mortality. Epidemiology. 2010;21(1):118-23.
21. Zetterstrom K, Lindeberg SN, Haglund B, Hanson U. The association of
maternal chronic hypertension with perinatal death in male and female
offspring: a record linkage study of 866,188 women. BJOG.
2008;115(11):1436-42.
22. Tuovinen S, Eriksson JG, Kajantie E, Lahti J, Pesonen AK, Heinonen
K, et al. Maternal hypertensive disorders in pregnancy and self-reported
cognitive impairment of the offspring 70 years later: the Helsinki Birth
Cohort Study. Am J Obstet Gynecol. 2013;208(3):200 e1-9.
23. Tuovinen S, Aalto-Viljakainen T, Eriksson JG, Kajantie E, Lahti J,
Pesonen AK, et al. Maternal hypertensive disorders during pregnancy:
adaptive functioning and psychiatric and psychological problems of the
older offspring. BJOG. 2014;121(12):1482-91.
24. Grace T, Bulsara M, Pennell C, Hands B. Maternal hypertensive
diseases negatively affect offspring motor development. Pregnancy
Hypertens. 2014;4(3):209-14.
25. Harper LM, Biggio JR, Anderson S, Tita AT. Gestational Age of
Delivery in Pregnancies Complicated by Chronic Hypertension. Obstet
Gynecol. 2016;127(6):1101-9.
26. American College of Obstetricians Gynecologists. Hypertension in
pregnancy. Report of the American College of Obstetricians and
Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol.
2013;122(5):1122-31.
27. Martin JA, Osterman MJ, Kirmeyer SE, Gregory EC. Measuring
Gestational Age in Vital Statistics Data: Transitioning to the Obstetric
Estimate. Natl Vital Stat Rep. 2015;64(5):1-20.
28. Gregory ECW, Martin JA, Argov EL, Osterman MJK. Assessing the
Quality of Medical and Health Data From the 2003 Birth Certificate
Revision: Results From New York City. Natl Vital Stat Rep.
2019;68(8):1-20.
29. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or
prevalence ratios and differences. Am J Epidemiol. 2005;162(3):199-200.
30. Harel O, Mitchell EM, Perkins NJ, Cole SR, Tchetgen Tchetgen EJ, Sun
B, et al. Multiple Imputation for Incomplete Data in Epidemiologic
Studies. Am J Epidemiol. 2018;187(3):576-84.
31. Rubin DB. Inference and missing data. Biometrika. 1976;63(3):581-92.
32. Ananth CV, Schisterman EF. Confounding, causality, and confusion:
the role of intermediate variables in interpreting observational studies
in obstetrics. Am J Obstet Gynecol. 2017;217(2):167-75.
33. Robins JM, Greenland S. Identifiability and exchangeability for
direct and indirect effects. Epidemiology. 1992;3(2):143-55.
34. Pearl J. Direct and Indirect Effects. Proceedings of the Seventeenth
conference on Uncertainty in artificial intelligence. 2001:411-20.
35. Valeri L, Vanderweele TJ. Mediation analysis allowing for
exposure-mediator interactions and causal interpretation: theoretical
assumptions and implementation with SAS and SPSS macros. Psychol
Methods. 2013;18(2):137-50.
36. Ananth CV, VanderWeele TJ. Placental abruption and perinatal
mortality with preterm delivery as a mediator: disentangling direct and
indirect effects. Am J Epidemiol. 2011;174(1):99-108.
37. Lash TL, Fox MP, Fink AK. Applying quantitative bias analysis to
epidemiologic data.: Springer-Verlag New York; 2009.
38. Lash TL, Fox MP, MacLehose RF, Maldonado G, McCandless LC, Greenland
S. Good practices for quantitative bias analysis. Int J Epidemiol.
2014;43(6):1969-85.
39. Episensr HD. Basic Sensitivity Analysis of Epidemiological Results.
R package 0.9.999. ed2020.
40. Premkumar A, Baer RJ, Jelliffe-Pawlowski LL, Norton ME. Hypertensive
Disorders of Pregnancy and Preterm Birth Rates among Black Women. Am J
Perinatol. 2019;36(2):148-54.
41. Kase BA, Carreno CA, Blackwell SC, Sibai BM. The impact of medically
indicated and spontaneous preterm birth among hypertensive women. Am J
Perinatol. 2013;30(10):843-8.
42. Hutcheon JA, Lisonkova S, Magee LA, Von Dadelszen P, Woo HL, Liu S,
et al. Optimal timing of delivery in pregnancies with pre-existing
hypertension. BJOG. 2011;118(1):49-54.
43. American College of Obstetricians Gynecologists, Committee on
Practice Bulletins, Obstetrics. ACOG Practice Bulletin No. 203: Chronic
Hypertension in Pregnancy. Obstet Gynecol. 2019;133(1):e26-e50.
44. Oshiro BT, Kowalewski L, Sappenfield W, Alter CC, Bettegowda VR,
Russell R, et al. A multistate quality improvement program to decrease
elective deliveries before 39 weeks of gestation. Obstet Gynecol.
2013;121(5):1025-31.
45. Niskanen L, Laaksonen DE, Nyyssonen K, Punnonen K, Valkonen VP,
Fuentes R, et al. Inflammation, abdominal obesity, and smoking as
predictors of hypertension. Hypertension. 2004;44(6):859-65.
46. Gurven M, Blackwell AD, Rodriguez DE, Stieglitz J, Kaplan H. Does
blood pressure inevitably rise with age?: longitudinal evidence among
forager-horticulturalists. Hypertension. 2012;60(1):25-33.
47. Chen A, Feresu SA, Fernandez C, Rogan WJ. Maternal obesity and the
risk of infant death in the United States. Epidemiology.
2009;20(1):74-81.
48. Jacobsson B, Ladfors L, Milsom I. Advanced maternal age and adverse
perinatal outcome. Obstet Gynecol. 2004;104(4):727-33.
49. Delbaere I, Verstraelen H, Goetgeluk S, Martens G, De Backer G,
Temmerman M. Pregnancy outcome in primiparae of advanced maternal age.
Eur J Obstet Gynecol Reprod Biol. 2007;135(1):41-6.
50. McDonald SD, Han Z, Mulla S, Beyene J, Knowledge Synthesis G.
Overweight and obesity in mothers and risk of preterm birth and low
birth weight infants: systematic review and meta-analyses. BMJ.
2010;341:c3428.
51. Pineles BL, Hsu S, Park E, Samet JM. Systematic Review and
Meta-Analyses of Perinatal Death and Maternal Exposure to Tobacco Smoke
During Pregnancy. Am J Epidemiol. 2016;184(2):87-97.
52. NIH. Chronic Hypertension and Pregnancy (CHAP) Project. 2020.